4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-034877
Chief Business Development Off sold 6,770 shares at $40.00 ($270,800)
- Chief Business Development Off acquired 6,770 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-06-03 | Option exercise | +2,604 | $6.55 | $17,056 | 2,604 | D |
| BENZENO SHARON Chief Business Development Off | 2020-06-03 | Option exercise | +2,604 | $6.55 | $17,056 | 5,208 | D |
| BENZENO SHARON Chief Business Development Off | 2020-06-03 | Option exercise | +1,562 | $7.27 | $11,356 | 6,770 | D |
| BENZENO SHARON Chief Business Development Off | 2020-06-03 | Sale | −6,770 | $40.00 | $270,800 | 0 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Business Development Off | 2020-06-03 | Option exercise · Stock Option (Right to Buy) | −2,604 | 43,271 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-06-03 | Option exercise · Stock Option (Right to Buy) | −2,604 | 72,917 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-06-03 | Option exercise · Common Stock (Right to Buy) | −1,562 | 48,438 | D | ||
| Open-market sales · 6,770 sh · avg $40.00 · $270,800 | |||||||
Loading xslF345X03/doc4.xml…